BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7880619)

  • 1. Soluble intercellular adhesion molecule-1 (ICAM-1) is released into the serum and ascites of human ovarian carcinoma patients and in nude mice bearing tumour xenografts.
    Giavazzi R; Nicoletti MI; Chirivi RG; Hemingway I; Bernasconi S; Allavena P; Gearing AJ
    Eur J Cancer; 1994; 30A(12):1865-70. PubMed ID: 7880619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble intercellular adhesion molecule 1 is released by human melanoma cells and is associated with tumor growth in nude mice.
    Giavazzi R; Chirivi RG; Garofalo A; Rambaldi A; Hemingway I; Pigott R; Gearing AJ
    Cancer Res; 1992 May; 52(9):2628-30. PubMed ID: 1348968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of soluble intercellular adhesion molecule-1 in endometriosis.
    Wu MH; Yang BC; Hsu CC; Lee YC; Huang KE
    Fertil Steril; 1998 Dec; 70(6):1139-42. PubMed ID: 9848307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tumour necrosis factor on human tumour xenografts in nude mice.
    Balkwill FR; Ward BG; Fiers W
    Ciba Found Symp; 1987; 131():154-69. PubMed ID: 3131073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of intercellular adhesion molecule-1 expression in human thyroid cells in vitro and human thyroid tissue transplanted to the nude mouse in vivo: role of Graves' immunoglobulins and human thyrotropin receptor.
    Hoermann R; Spitzweg C; Poertl S; Mann K; Heufelder AE; Schumm-Draeger PM
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2048-55. PubMed ID: 9215271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice.
    Kawai K; Enomoto T; Fornasier V; Resetkova E; Volpé R
    Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intraperitoneal recombinant interleukin-1 beta in intraperitoneal human ovarian cancer xenograft models: comparison with the effects of tumour necrosis factor.
    Malik ST; East N; Boraschi D; Balkwill FR
    Br J Cancer; 1992 May; 65(5):661-6. PubMed ID: 1586593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of intercellular adhesion molecule-1 on human thyroid cells from patients with autoimmune thyroid disease: study of thyroid xenografts in nude and severe combined immunodeficient mice and treatment with FK-506.
    Arreaza G; Yoshikawa N; Mukuta T; Resetkova E; Barsuk A; Nishikawa M; Muallim C; Miller N; Jamieson C; Volpé R
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3724-31. PubMed ID: 8530625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tumor size on the enhancement by gamma interferon of the localization of radiolabeled F(ab')2 fragments of anti-intercellular adhesion molecule-1 monoclonal antibodies in human colon carcinoma cells grafted in nude mice.
    Matsui M; Yoshimura S; Nakanishi T; Ferrone S
    Cancer Res; 1992 Mar; 52(5):1309-13. PubMed ID: 1346588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal mesothelial cells as a significant source of ascitic immunostimulatory protein 90K.
    Zeimet AG; Stadlmann S; Natoli C; Widschwendter M; Hermann M; Abendstein B; Daxenbichler G; Offner FA; Iacobelli S; Marth C
    Anticancer Res; 2000; 20(6B):4507-11. PubMed ID: 11205296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines.
    Nash MA; Lenzi R; Edwards CL; Kavanagh JJ; Kudelka AP; Verschraegen CF; Platsoucas CD; Freedman RS
    Clin Exp Immunol; 1998 May; 112(2):172-80. PubMed ID: 9649178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative transfection studies of human ovarian carcinoma cells in vitro, ex vivo and in vivo with poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes.
    van de Wetering P; Schuurmans-Nieuwenbroek NM; Hennink WE; Storm G
    J Gene Med; 1999; 1(3):156-65. PubMed ID: 10738564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOv19.
    Mantovani LT; Miotti S; Ménard S; Canevari S; Raspagliesi F; Bottini C; Bottero F; Colnaghi MI
    Eur J Cancer; 1994; 30A(3):363-9. PubMed ID: 8204360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of DF3, in association with ICAM-1 and MHC class II by IFN-gamma in short-term human mammary carcinoma cell cultures.
    Sgagias MK; Nieroda C; Yannelli JR; Cowan KH; Danforth DN
    Cancer Biother Radiopharm; 1996 Jun; 11(3):177-85. PubMed ID: 10851535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cytokines combined with high-dose gamma irradiation on the expression of major histocompatibility complex molecules and intercellular adhesion molecule-1 in human ovarian cancers.
    Santin AD; Rose GS; Hiserodt JC; Fruehauf J; Eck LM; Garcia RI; Schranz V; Disaia PJ; Pecorelli S; Granger GA
    Int J Cancer; 1996 Mar; 65(5):688-94. PubMed ID: 8598323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of gamma-interferon in ascitic and solid tumor models of human ovarian cancer.
    Malik ST; Knowles RG; East N; Lando D; Stamp G; Balkwill FR
    Cancer Res; 1991 Dec; 51(24):6643-9. PubMed ID: 1742738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is human leukocyte antigen-DR and intercellular adhesion molecule-1 expression on human thyrocytes constitutive in papillary thyroid cancer? Comparative studies in human thyroid xenografts in severe combined immunodeficient and nude mice.
    Kawai K; Resetkova E; Enomoto T; Fornasier V; Volpé R
    J Clin Endocrinol Metab; 1998 Jan; 83(1):157-64. PubMed ID: 9435434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combination of the tyrosine kinase receptor inhibitor SU6668 with paclitaxel affects ascites formation and tumor spread in ovarian carcinoma xenografts growing orthotopically.
    Garofalo A; Naumova E; Manenti L; Ghilardi C; Ghisleni G; Caniatti M; Colombo T; Cherrington JM; Scanziani E; Nicoletti MI; Giavazzi R
    Clin Cancer Res; 2003 Aug; 9(9):3476-85. PubMed ID: 12960140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.